chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vaccinated on 10/03/2019 / second dose is not administered yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 3rd October 2019, batch number PF454, expiry date 26th January 2022).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the second dose was not administered to the patient, which led to incomplete course of vaccination. The VAERS details were reported for 1st dose. The reporter consented to follow up and healthcare professional gave consent to follow up.
pt rcvd vax; area of vax w/ reddened streaks, warm to touch w/ localized edema;
received 3 doses of Shingrix; rash; pain; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 64-year-old female patient who received Herpes zoster (Shingrix) (batch number 924T3, expiry date 3rd June 2022) for prophylaxis.   Previously administered products included Shingrix (received 2 doses of Shingrix on unknown date).   On 8th July 2020, the patient received the 3rd dose of Shingrix. On 8th July 2020, unknown after receiving Shingrix, the patient experienced extra dose administered. In July 2020, the patient experienced rash and pain. On an unknown date, the outcome of the rash, pain and extra dose administered were unknown.   It was unknown if the reporter considered the rash and pain to be related to Shingrix.  Additional details were provided as follows: The patient received 3 doses of Shingrix, which led to extra dose administered and patient experienced rash and pain. The reporter consented to follow up. Batch Number and Expiration Date for 3rd dose administered were reported.
I tested positive for Covid 19 on April 1, 2023 I experienced sinus congestion; cough; tired; headache; oxygen level was 83% I was prescribed Paxlovid for my symptoms.
This individual was less than 18 years of age at the time of vaccination.  His age on the application form list as 18 hoverer, the Date of Birth is listed as August 12, 2004.
This is a spontaneous report from a contactable consumer or other non hcp. A 64-years-old male patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot Number: 30130D7), dose 3 via an unspecified route of administration, administered in Arm Right on 07Oct2021 07:55 as dose 3 (booster), single for covid-19 immunisation. Medical history included asthma Stated that he has had asthma for a few years. Stated that he was diagnosed two years ago.The patient's concomitant medications were not reported. Patient previously took first dose 1 and second dose of bnt162b2 (BNT162B2, solution for injection), via unspecified route of administration, administered on unknown date (Batch/Lot Number: unknown), as single dose for covid-19 immunisation. It was reported that, on 07Oct2021 20:00 patient experienced tired, dizzy, nauseous and had confusion, about 5 minutes after the shot at 8:00pm. Stated that he felt depressed and angry after 8pm.The outcome of the event malaise was unknown and rest all other events were not recovered. Follow-Up (15Oct2021): Follow-up attempts are completed. No further information is expected.
Woke up achy all over with fever and chills. BP was high, so took meds, but didn't help even after taking again later. Contacted physician and advised to come in. Different BP med given that helped. Woke up tired the next morning.
Patient stated that she was having shortness of breath about an hour after administration. She came back to pharmacy and took 50mg of diphenhydramine. She left and went back home because she did not want me calling 911. She called and stated that she was feeling better around 12:08pm. At 12:15pm, patient called back and said she was feeling dizzy and lightheaded (probably a result of the diphenhydramine) but still having some shortness of breath. She was instructed to call 911. When paramedics came, they believed her symptoms were consistent with a panic attack and did not take her to the ER. She was told to call them back if her symptoms got worse, and then they would transport her to the ER.
Information has been received from a physician conerning a 68 year old female patient who on 20-APR-1999 was vaccinated with the first dose of PNWUMOVAX 23 vaccine IM. On 21-APR-1999, the patient experienced redness, swelling, induration, pain, and a hot sensation at the injection site. Additionally the patient had difficulty sleeping. The patient sought unspecified medical treatment and was treated with ADVIL and ice for the symptoms. Additional information has been requested.
After receiving the vaccine started feeling throat tingling. Benadryl was administered 25 mg by mouth and was place in observation for 30 minutes by the Dr. It felt better and has been stable since then.
On 12/26, I woke up with a headache, nausea, and feverish without a temp. They resolved by 12/28. I was tested for Covid on 12/26, results pending
Local reaction, 1-2cm errhythema with fever up to 101F, according to mom, advised continue tylenol every 4-6 hours, warm compress to site, f/u with MD for injury to arm from kerosene heater
Developed Afib with RVR that would resolve within a few hours.  This occurred without  patient's awareness of the underlying condition until admittance on October 20th to local Hospital for Afib with RVR and a heartrate of 165.  IV treatment with Metoprolol.ended the Afib.  Once under control, began ongoing treatment with cardiologist Dr.    Now take Metoprolol 12.5mg two times a day, and have had one recurrance of Afib that resolved within  a few hours.  Also note, my husband had the Moderna two dose vaccine on the same dates as me, and he also developed Afib  ( 12/14/1959)
Rash all over my body, itchy, within 1.5 hours of receiving shot. Took Benedryl. Went away. When Benedryl wears off, rash comes back. Low grade fever developed 7 Pm first night and has been going away and coming back for two days along with chills. Extremely thirsty. Soreness of arm where injection was done. Redness. Occurred next day. Been using ice packs on arm and face. Face has bad rashes. Muscle and joint pains for the last day and a half.
pain in lymphnodes that started a week after vaccination and was felt for 5 days. pain started again a 8 days after initial pain in arm pit.
Pt said he had pain in shoulder and arm felt weak and it felt like it settled in socket, when vaccine was given in the deltoid, it was very painful to move around and it hurt.
This spontaneous report was received from an unspecified reporter regarding a 65 year old female patient with neosporin allergy and shellfish allergy. The patient's medical history included asthma and arthritis. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot#, dose, route not reported). No concomitant medications were reported. On 28-DEC-2012, the patient experienced muscle pain and weakness in lower part of legs and now in arms, rash in various parts of body, notices it first on neck and arms, some kind of allergy with eyes and severe joint pain. Patient received TYLENOL (reported as TYLENOL) for pain. Patient sought medical attention. Doctor did six different blood tests which all came back negative. The outcome of the events were reported as not recovered. The relatedness of the events with ZOSTAVAX was unknown. Additional information has been requested.
Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild; symptoms lasted 2 days
slight achiness to upper back; slight inability to focus on complex tasks; Reduced sense of taste; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 14:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history included hemochromatosis. Concomitant medications included allopurinol (MANUFACTURER UNKNOWN) and fexofenadine hydrochloride (ALLEGRA), both  from unknown dates for unknown indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration on 10Mar2021 at 11:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 12:00, the patient experienced slight achiness to upper back, then slight inability to focus on complex tasks, then reduced sense of taste. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events slight achiness to upper back, slight inability to focus on complex tasks and reduced sense of taste was recovered with lasting effects.   No follow-up attempts are needed. No further information is expected.
sore throat; cough; night sweats; skin feeling like it was on fire; Arm hurt really bad; chills; low grade fever of 99-100F; sweating; Scratchy throat; headache; fatigue; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire) and PAIN IN EXTREMITY (Arm hurt really bad) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from 20-Dec-2020 to 30-Dec-2020. Concurrent medical conditions included Gluten sensitivity and Milk allergy. Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for Blood pressure abnormal, ALPRAZOLAM (LAMPRO) for Mood altered, LEVOTHYROXINE and THYROID (ARMOUR THYROID) for Thyroid disorder NOS, LAMOTRIGINE for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPERHIDROSIS (sweating), THROAT IRRITATION (Scratchy throat), HEADACHE (headache) and FATIGUE (fatigue). On 21-Jan-2021 at 12:00 PM, the patient experienced OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire), PAIN IN EXTREMITY (Arm hurt really bad), CHILLS (chills) and PYREXIA (low grade fever of 99-100F). On 24-Jan-2021, OROPHARYNGEAL PAIN (sore throat), COUGH (cough), NIGHT SWEATS (night sweats), SKIN BURNING SENSATION (skin feeling like it was on fire), PAIN IN EXTREMITY (Arm hurt really bad), HYPERHIDROSIS (sweating), THROAT IRRITATION (Scratchy throat), HEADACHE (headache), FATIGUE (fatigue), CHILLS (chills) and PYREXIA (low grade fever of 99-100F) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Within one hour of receiving vaccine, the patient experienced cough and scratchy throat, by 3 pm the patient experienced chills. At 6 pm, chills turned into low grade fever. The patient's arm hurt really bad. Fatigue with sweating persisted for the next day. On 24-Jan-2021, all the symptoms were resolved.   This case was linked to MOD-2021-065097 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: additional events of arm hurt really bad, scratchy throat added, outcome of events changed to resolved, first dose date changed, event onset dates changed as per follow up received; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
vasculitis; coughing up blood; really bad head cold; dizzy; Started gettting sick; A spontaneous report received from a Consumer concerning, 79-year-old, female patient who received dose of Moderna COVID-19 vaccine experienced Vasculitis.   The patient's medical history included Afib. Patient's concomitant included Eliquis.    On 04FEB2021, the patient received their 1st dose of the two planned doses of mRNA-1273 in left arm (Batch #: unknown) intramuscularly for prophylaxis of COVID-19 infection.   Patient daughter reports her mother who is 79-year-old female with no underlining health issues other than Afib, which she takes blood thinners for has been in ICU since 10FEB2021. Patient daughter stated that she was told her mother has vasculitis as a result of the Moderna Covid-19 vaccine.   Patient daughter stated that her mother started getting sick on 06Feb2021. She stated her mother started coughing up blood on Sunday 07FEB2021. She stated her mother also had a bad head cold and was dizzy. Patient daughter stated that her mother has some genetic predisposition and the Moderna COVID-19 vaccine triggered it.   Patient daughter stated that her mother doctor advised her not to receive the 2nd dose of the Moderna COVID-19 vaccine.   Patient treatment included Chemotherapy Infusion (Rituxan) and Blood Transfusion.   Action taken with mRNA-1273 in response to the event was withdrawn.   The outcome of the event was unknown/not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
12 hours after receiving the vaccine (at 11:00pm on Saturday), I woke with nausea, stomach pains and the chills. I was up the remainder of the night. By morning I had a bad headache and terrible body/muscle aches. I was unable to report to work that day. By midafternoon, the nausea and stomach pains subsided, all other symptoms remained along with then getting a 100.5 fever. I was taking Tylenol every 4 hours since 1am and keeping hydrated. By midnight I was exhausted and was finally able to sleep. I woke the following morning with a dull headache and just felt achy. I felt much better by that evening (now Monday). Tuesday morning I woke with discomfort to my left armpit and clavicle area. I then noticed swelling, the areas felt ?lumpy? and were very tender to touch. That lasted about 2 days.
After 1st HPV patient reports, she had eye twitching for a while. She also reports today that after the second HPV injection she had what sounds like myoclonus- twitching jerks of bilateral arms & legs, beginning a couple of weeks after the shot and then slowly subsiding.
This case was reported by a pharmacist via sales rep and described the occurrence of chronic myeloid leukemia in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced chronic myeloid leukemia (serious criteria GSK medically significant) and multiple myeloma (serious criteria GSK medically significant). On an unknown date, the outcome of the chronic myeloid leukemia and multiple myeloma were unknown. It was unknown if the reporter considered the chronic myeloid leukemia and multiple myeloma to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX, later was diagnosed with multiple myeloma and CML. The reporter was interested in safety data to make decision on 2nd dose. The reporter did not agree to follow up from GlaxoSmithKline. Clarification has been raised for diagnosed event.
Patient lost consciousness and fell on the floor 5 mins after receiving the shot. He had no response to any physical contact. His pulse was weak and pupils were dilated.  One dose of 0.3mg Epipen was then given to the left thigh of patient.  He regained consciousness in about 5 mins after the Epipen shot. His pulse and pupils turned back to normal  as well. He was able to stand and answer questions to the EMS team when they arrived to the scene in another 5 mins.  Patient was then taken to the ambulance.
Elevated heart rate, shortness of breath, tingling in hands, muscle cramping in hands, ears throbbing
Pretty sore especially to the touch, somewhat itchy spot on my arm at the injection site.  There is a 1.5 inch wide by 2.5 inch tall red blotchy shaped spot where the injection side was. Arm is slightly sore when lifting above my head but if the red blocky spot is touched it hurts but does not hurt touching anywhere outside the red spot.  It?s not bothersome enough to get medical attention but I?ve never had any reaction to any shot or medication in the past and read this is rare so thought it was worth reporting.
RETARDED; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced retarded. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of retarded was not reported. This report was non-serious.
Received simultaneous flu and Pfizer Covid vaccine (3rd dose) on September 28. 30 hours later woke up with right thigh pain. Worsened over the next three days and evolved to include low back through knee. Essentially bed-ridden, unable to ambulate any significant amount without crutches or severe pain. Writhing in pain virtually around the clock. Associated numbness and weakness L3-L4. Rt hip film showed mild arthritis. PCP suggested physical therapy, with essentially no appreciation that I had gone from walking 6 miles a day/swimming/tennis to bedridden status. Lumbar MRI on day 19 showed bulging discs and stenosis ( worse on left -the "good" side) which I regard as old findings (please note I am a physician, board certified in /Internal Medicine and Radiation Oncology). Pain gradually started to subside at three weeks. Pain-free at 6-7 weeks. Numbness seems largely gone, now at 7 weeks.  My suspicion is that this was an inflammatory neuritis, presumably related to the Covid vaccine (acknowledging that a flu shot was given concurrently).
Patient diagnosed with Covid 19 on 11/02/2021 and received monoclonal antibody treatment.  Patient presented to Medical Center on 11/07/2021 worsening SOB and hypoxemia.  Patient was placed on Vapotherm and admitted to hospital.  Patient received Remdesivir, Dexamethasone, prone positioning as able, Vapotherm, Lovenox.  He also presented with acute pulmonary embolus.  11/19/2021 Patient started to require BiPAP at night.  11/20/2021: Patient was moved to ICU and BiPAP was started.  11/25/2021 Patient developed increased SOB and tachycardia, he was unable to maintain his oxygen saturation and was emergently intubated.  Patient developed asystole and expired on 11/27/2021.
hives w/itch over all body;pt recv vax 28OCT98 530PM-hives Thursday took DPh-went to hosp Sunday;rx w/IV DPH & ATB;
Patient reported slight difficulty breathing, redness/itching. Gave patient Benadryl and had patient stay in the pharmacy for continuing monitoring. Patient symptoms did resolve after a few minutes and was well enough to head home after with someone to bring her home (we didn't want her to drive drowsy). We did keep patient in the pharmacy for 30 minutes monitoring. Did tell patient to go to her primary doctor to discuss whether she should receive the second dose and if she may need to pre-medicate.
Information has been received from an office manager at a physician practice concerning a 10 year old male patient with no drug reactions/allergies who in 2001, at "age one", was vaccinated with a dose of VARIVAX (Merck) and now he had confirmed chickenpox (on approximately 08-MAY-2010). The patient had several itchy lesions all over the body. The school nurse reported that there was an outbreak of chickenpox at school with 20 cases. The patient had an office visit on 08-MAY-2010. Specimen was sent for testing (result not provided). At the time of the report the patient's status was unknown. Additional information has been received from a health care worker regarding a WPS letter they received. No further information is provided. Follow up information has been received from a physician concerning the 10 year old male patient who on 29-JAN-2001 was vaccinated SC in the left leg with the first dose of VARIVAX (Merck) (Lot# 636569/0926K). On 08-MAY-2010 the patient had confirmed chickenpox. No rash occurred at the site of injection or elsewhere within 42 hours of the vaccination. The specimen was collected for PCR and result of PCR was positive. There was no photo taken. The patient had no recent exposure to chickenpox or herpes zoster. Physician exam revealed the patient was afebrile at 98.7 and with multiple itchy lesions all over his body. The one on the right forearm now was crusting but the others were still flat and bright pink macules or some had microvesicles in the center. The patient had several on his scalp now as well and one on the bottom of the left foot. The patient's father reported that the patient woke up with some on his face yesterday morning and before that which he thought he just had bug bites. The physician thought the patient was contagious for chickenpox at school and the school should be alerted. A viral culture was taken from a blister, a tiny microvesicle on his back and would be sent to the laboratory for culture. The patient should be bathed with a quarter to half cup each of baking soda and cornstarch and frequent bathing could keep these spots from getting infected. The physician also recommended TYLENOL or MOTRIN for fever or discomfort and should generic to avoid the recalled forms. The patient recovered at the time of report. Additional information is not expected.
Topical reaction confirmed by MD as head to toe whole body papular rash 4 hours after recieving immunizations.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history, drug reactions/allergies and concomitant medications were not reported. On 09-NOV-2017, the patient was inadvertently vaccinated with an expired and improperly stored dose of PNEUMOVAX 23 for prophylaxis (dose and route were unknown; lot # L034335, expiry date: 18-MAY-2017). The vaccine underwent a temperature of 22C for a timeframe of 5 and 1/2 months (from end of May 2017 until 08-NOV-2017). There was not previous temperature excursion and data logger was not involved. In November 2017, the patient experienced itching at the site of injection (Injection site pruritus). The outcome of injection site pruritus, was unknown.  The causality assessment between PNEUMOVAX 23 and injection site pruritus was not reported.